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There has been recent interest in the possibility that breast cancer
can have a prenatal origin (Trichopoulos, 1990). Various studies
have reported on the relationship between birthweight, taken as a
marker of prenatal environment, and breast cancer, but with
differing results. One study (Ekbom et al, 1992; 1997) reported no
association between birthweight and breast cancer, two (Le
Marchand et al, 1988; Sanderson et al, 1996) an inverse relation-
ship, and one (Michels et al, 1996) a positive association. The
latter was a case-control study nested within the US Nurses’
Cohort, which found that the odds of breast cancer for women who
weighed 4 kg or more at birth was twice that of women who
weighed less than 2.5 kg (Michels et al, 1996). The relationship
was strongest for women aged 50 or younger.
Various factors might explain the inconsistency of these results.
In some studies the information on birthweight was based on recall
by the women themselves or their mothers (Michels et al, 1996;
Sanderson et al, 1996), in most no account was taken of adult-life
risk factors for breast cancer (Ekbom et al, 1992; 1997; Le
Marchand et al, 1988), and no account was taken in any of child-
hood and pubertal factors.
The present study examines the relationship between birth-
weight and breast cancer in a UK national cohort of 2221 women
who have been followed since their birth in 1946, and for whom
data on birthweight, markers of childhood growth and adult-life
risk factors for breast cancer have been recorded.
DATA AND METHODS
The Medical Research Council National Survey of Health and
Development (NSHD) is a socially stratified birth cohort of 2548
women and 2814 men born in the UK during the week 3–9 March
1946 (Wadsworth, 1991; Wadsworth and Kuh, 1997). The cohort
comprised single, legitimate births to wives of all non-manual and
agricultural workers and to 1 in 4 wives of manual workers. There
have been 19 follow-up contacts with the cohort members between
their birth and age 43 years, most by home interviews. The sample
interviewed at age 43 years were, in most respects, representative
of the native population of that age (Wadsworth et al, 1992). Since
1993, when the cohort members were 48 years of age, a postal
health questionnaire has been sent annually to all women in the
study with whom there was still direct contact. At these separate
contacts, breast cancer diagnosis was self-reported and recorded.
In 1971, when the National Health Service Central Register
(NHSCR) started to record cancers occurring in the population of
the UK, all cohort members (including those with whom there
was no longer direct contact) were ‘flagged’ at the NHSCR. This
provided notification of registrations of cancer, death and emigra-
tion for the cohort.
Information on birthweight was extracted from the birth records
of the cohort members and categorized into four groups:
< 3.000 kg, 3.000–3.499 kg, 3.500–3.999 kg, ³ 4.000 kg, in
accord with previous studies (Ekbom et al, 1997; Michels et al,
1996). Data on maternal age and birth order were collected at the
original home visit. Data on childhood and adult risk factors, that
might confound or modify the relation of birthweight with breast
cancer, were recorded at follow-up contacts. Childhood social
class was assigned from father’s occupation when the cohort
member was aged 4 years or, if this was unknown, when aged 7 or
11. Height and weight were measured prospectively throughout
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1981); the values recorded at age 7 and 36 years were a priori
selected for this analysis as markers of pre-pubertal growth and
adult size, respectively. Age at menarche was obtained from ques-
tions to mothers when survey members were aged 11 and 15 years
(Cooper et al, 1996) or, failing this, from the women themselves at
the age of 48 years (n = 101). The dates of all live births to the
women in the cohort have been updated through follow-up
contacts and were used to obtain age-at-first-live-birth and parity.
Of the 2548 women who had been in the birth cohort, 2221
(87%) were included in the analyses. Of the 327 who were
excluded, 299 had died or emigrated before 1971, 17 could not be
flagged and 11 had no birthweight recorded.
Follow-up was analysed from 1 January 1971, when the women
were aged 24 years and 9 months. For those who had not returned
any of the postal questionnaires (n = 660), follow up was analysed
until the earliest of the following: breast cancer diagnosis, death,
emigration or 31 December 1992 (the last date for which the
NHSCR cancer registration data were considered to be complete at
the time of this analysis). For women who had returned at least one
questionnaire (n = 1561), follow-up was until the earliest of: breast
cancer diagnosis or last completed questionnaire (up to 1997).
Since breast cancer may have a different aetiology at pre- and
postmenopausal ages, events and follow-up prior to menopause
were examined separately. Menopausal status could only be ascer-
tained through the postal questionnaires, hence only women who
responded to at least one questionnaire were considered. Two of
these 1561 women gave insufficient information to determine
menopausal status and were excluded. The premenopausal follow-
up of the remaining 1559 women was then defined from 1 January
1971 to the earliest of: breast cancer diagnosis, date of natural
menopause (defined retrospectively after 12 months of amenor-
rhoea), date of hysterectomy (or bilateral oophorectomy), start of
hormone replacement therapy (HRT), or date of last completed
questionnaire (up to 1997).
Statistical methods
A Cox regression model was used in the analyses, with age as the
time-scale of interest because of the expected associations between
attained age, breast cancer incidence and most of the factors to be
studied (Clayton and Hills, 1993). Plots of cumulative breast
cancer incidence rates for separate birthweight categories were
examined to assess their effect over different ages and to check the
proportional hazards assumption underlying the Cox model.
Univariate analyses provided age-adjusted rate ratios (RRs) by
birthweight category. These were re-examined after adjustments
for the effects of other perinatal and later-life factors. Since most
of these potential confounders had considerable numbers of
missing observations, their influences on the estimated effect of
birthweight were examined separately. Subsets of women with
information on each potential confounder were created and the
age-adjusted RR for binary birth weight (³ 3.5 kg vs < 3.5 kg) was
compared with that additionally adjusted for the relevant factor.
Potential confounding was judged on the extent of the relative
difference between these two estimates. Effect modification was
assessed via likelihood ratio tests for the significance of the interac-
tion between birthweight and each categorical factor. Lastly, all
these analyses were repeated with restriction to premenopausal ages.
RESULTS
A total of 37 breast cancer cases occurred during the follow-up
period. Twenty were identified through cancer registrations of
which 14 (70%) were also self-reported and 17 were only
self-reported. The median age at breast cancer incidence for the 37
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Table 1 Breast cancer incidence rates and age-adjusted rate ratios (RRs) for birthweight, by age
Birthweight Women Breast cancer Rate Age-adjusted analysis
(kg) n (%) cases (n) (per 100 000 p-yrs) RR (95% CI)
All ages (n = 2221)
Categorical
< 3.000 570 (26) 7 50.7 1
3.000–3.499 828 (37) 11 54.6 1.05 (0.41, 2.71)
3.500–3.999 657 (30) 15 92.9 1.76 (0.72, 4.33)
³ 4.000 166 (7) 4 99.8 2.02 (0.59, 6.90)
Test for linear trenda c2
(1) = 2.25, P = 0.13
Binary
< 3.500 1398 (63) 18 53.0 1
³ 3.500 823 (37) 19 94.3 1.76 (0.92, 3.35)
Test for heterogeneityb c2
(1) = 2.91, P = 0.09
Premenopausal agesc (n = 1559)
Categorical
< 3.000 385 (24) 2 22.7 1
3.000–3.499 588 (38) 6 45.1 1.99 (0.40, 9.86)
3.500–3.999 479 (31) 8 73.4 3.26 (0.69, 15.36)
³ 4.000 107 (7) 3 124.6 5.65 (0.95, 33.84)
Test for linear trenda c2
(1) = 4.62, P = 0.03
Binary
< 3.500 973 (62) 8 36.2 1
³ 3.500 586 (38) 11 82.7 2.31 (0.93, 5.74)
Test for heterogeneityb c2
(1) = 3.30, P = 0.07
aLikelihood ratio test calculated from the Cox regression model using the median value in each category as score; bLikelihood ratio test calculated from the Cox
regression model for the significance of the ³ 3.500 kg birthweight indicator; cThe number of women included in these analyses is smaller than that used in the
all-age analyses because menopausal status could only be ascertained for women who replied to at least one postal questionnairecases was 46.8 years (range: 36.3–51.2) and the median age at the
end of follow-up for the remaining 2184 women was 51.6 years
(range: 25.2–51.6). Of the 1559 women for whom menopausal
status was known at the end of follow-up, 19 were premenopausal
breast cancer cases.
All-ages breast cancer incidence rates increased with increasing
birthweight (Table 1). When the cumulative incidence rates for the
four birthweight categories were plotted against attained age (on a
logarithmic scale), they were roughly parallel, indicating that the
birthweight effect on breast cancer risk was constant over time.
Hence the age-adjusted RRs estimated by the Cox regression
model represent the overall effects of birthweight over the entire
age span analysed in this study. The RRs show a two-fold increase
in breast cancer rates for women whose birthweight was at least
4 kg, relative to those who weighed less than 3 kg, and a consistent
trend through the four weight categories (Table 1). Using a binary
classification (< 3.5 kg vs ³ 3.5 kg) the constant effect of birth-
weight, with consistently higher rates in the heavier birthweight
group, was still evident (Figure 1). Breast cancer rates for women
whose birthweight was greater than or equal to 3.5 kg were over
70% greater in comparison with those for women who were lighter
(RR = 1.76, 95% CI: 0.92, 3.35; Table 1). The premenopausal
analyses showed a stronger effect of birthweight with a steady
increase in rates across the birthweight categories (test for linear
966 BL De Stavola et al
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Figure 1 Cumulative breast cancer incidence rates by birthweight
Table 2 Rate ratios (RRs) for birthweighta with and without adjustment for selected potential confounders; all ages
Age-adjusted analysis
Age and confounder
Potential confounderb Breast adjusted analysis Test for
Womenb–c cancer casesc interactiond
(n)( n) RR (95% CI) RR (95% CI)
None 2221 37 1.76 (0.92, 3.35) – –
Maternal age 1929 31 1.98 (0.97, 4.01) 2.08 (1.02, 4.23) 0.09
Birth order 2220 37 1.76 (0.92, 3.34) 1.97 (1.03, 3.78) 0.29
Childhood social class 2101 34 2.09 (1.06, 4.12) 2.09 (1.06, 4.12) 0.55
Weight at 7 years 1850 31 2.02 (0.99, 4.09) 2.07 (1.00, 4.29) 0.23
Height at 7 years 1909 32 2.11 (1.05, 4.24) 2.00 (0.98, 4.06) 0.03
Age at menarche 1687 30 2.18 (1.06, 4.49) 2.21 (1.07, 4.55) 0.05
Adult height 1631 31 2.07 (1.02, 4.19) 1.95 (0.95, 4.03) 0.52
Age at first birth 1608 28 2.23 (1.06, 4.72) 2.24 (1.06, 4.74) 0.26
Parity 1608 28 2.23 (1.06, 4.72) 2.17 (1.03, 4.60) 0.21
Weight at age 36 years 1634 31 2.06 (1.02, 4.18) 2.03 (0.99, 4.14) 0.21
aBirth weight was included in the Cox regression model as a binary indicator coded <3.5 kg and ³3.5 kg; b’maternal age’ was coded as < 30, ³ 30 years; ‘birth
order’ as 1st, 2nd, 3rd, 4th or more; ‘age at first birth’ as < 20, 20–29, ³ 30 years, nulliparous; ‘parity’ as 0, 1, 2, ³ 3; ‘childhood social class’ as I & II, III non-
manual, III manual, IV & V; all weight and height measurements were categorized into quartiles; ‘age at menarche’ was classified as < 12, 12–13, ³ 14 years;
cThe number of women, and breast cancer cases, included in each analysis varied because of missing data for the different potential confounders; dP-value
from likelihood ratio test for interaction between binary birthweight and the factor listed in each row
Table 3 Breast cancer incidence rate ratios (RRs) in relation to birthweight and height at age 7 years, by age
Exposure categories Women Breast cancer Age-adjusted analysis
Birthweight Height at age 7a (n) cases (n)
(kg) (m) RR (95% CI)
All ages (n = 1909)b
< 3.5 < 1.22 or ³ 1.22 1194 14 1.00
³ 3.5 < 1.22 486 7 1.21 (0.49, 2.99)
³ 3.5 ³ 1.22 229 11 4.01 (1.82, 8.83)
Test for heterogeneityd c2
(2) = 10.75, P = 0.005
Premenopausal ages (n = 1351)c
< 3.5 < 1.22 or ³ 1.22 836 6 1.00
³ 3.5 < 1.22 345 3 1.23 (0.31, 4.91)
³ 3.5 ³ 1.22 170 7 5.86 (1.97, 17.44)
Test for heterogeneityd c2
(2) = 9.77, P = 0.008
aCategories based on quartiles of the height distribution: bottom three quartiles (< 1.22 m) vs top quartile (³ 1.22); bThe number of women included in this
analysis is less than 2221 because of missing values for height at age 7; cThe number of women included in this analysis is less than 1559 because of missing
values for height at age 7; dLikelihood ratio test calculated from the Cox regression model for the significance of the heterogeneity of the RRs for the three
exposure categoriesGrowth and breast cancer 967
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trend: P = 0.03); the RR corresponding to the binary classification
of birthweight was greater than 2 (Table 1).
Table 2 shows the results of adjusting the all-ages RR for binary
birthweight for different potential confounders. There is some
evidence of confounding due to maternal age, birth order and adult
height, as the age-adjusted RR for birthweight changes by at least
5% when additionally adjusted for any of these factors. A signifi-
cant interaction between birthweight and quartiles of height at age
7 years (P = 0.03) is observed, with the effect of birthweight being
stronger in taller girls. There is also a borderline significant inter-
action between birthweight and age at menarche (P = 0.05), with a
stronger effect of birthweight in girls with earlier puberty.
Adjustment for the other variables in the table as well as body
mass index at ages 7 and 36 years (results not shown), did not
affect the original birthweight estimates.
Since height at age 7 and age at menarche were negatively
correlated (Spearman’s correlation coefficient = –0.17, P < 0.001)
the separate interactions between these two factors and birth-
weight are likely to be a reflection of the same process. Indeed the
median age at menarche of the women in the top quartile of height
at age 7 was 7 months earlier than that of women who were not so
tall at 7 years. When the two interactions were included in the
same model, only the one between birthweight and height at age 7
remained significant (P = 0.04), while that with age at menarche
became redundant (P = 0.18).
To examine this further without creating too many strata, we
regrouped height at age 7 as a binary variable (the first three quar-
tiles vs the fourth, i.e. < 1.22 m vs ³ 1.22 m) and modelled its
interaction with birthweight using three groups: birthweight
<3.5 kg (baseline); birthweight ³ 3.5 kg and height at age
7 < 1.22 m; birthweight ³ 3.5 kg and height at age 7 ³ 1.22 m
(Table 3). The baseline group included all low-birthweight girls
without distinction by height at age 7 because of small numbers.
The effect of this three-category factor on breast cancer rates was
highly significant (P = 0.005). Women who were heavy at birth
and short or average at age 7 were estimated to have a 21%
increase in breast cancer rates, relative to women who were light at
birth (RR = 1.21, 95% CI: 0.49–2.99). Women who were heavy at
birth and tall at age 7 had a four-fold increase (RR = 4.01, 95% CI:
1.82–8.83). These results did not materially change after adjusting
separately for each of the potential confounders considered in
Table 2. There was evidence of a similar, although weaker, modifi-
cation of the effect of birthweight due to height at age 6 (P = 0.05)
and 11 (P = 0.06) but no modification due to height at ages 2
(P = 0.34) and 15 (P = 0.19).
In analyses repeated on data restricted to premenopausal ages,
the interaction between birthweight and height at age 7 was
slightly stronger than that for the complete data set, with those
who were heavy at birth and tall at 7 years having an almost six-
fold increase in breast cancer rates relative to those who were light
at birth (Table 3).
DISCUSSION
In a UK national cohort of women born immediately after World
War II, birthweight was positively associated with breast cancer,
which persisted after adjustment for other perinatal and later-life
factors.
In agreement with previous studies (Michels et al, 1996;
Sanderson et al, 1996) the effect of birthweight on breast cancer
risk was particularly marked at premenopausal ages. Women who
weighed 4 kg or more at birth were nearly six times more likely to
develop breast cancer prior to menopause than those who weighed
less than 3 kg. In contrast to the US Nurses’ Cohort study (Michels
et al, 1996), however, the effect of birthweight found in our study
was not restricted to the extreme values of its distribution. Breast
cancer risk at premenopausal ages rose gradually for successive
categories of increasing birthweight, although the estimates were
based on small numbers.
Our study had several strengths. Information on birthweight
was obtained prospectively from routinely completed birth records
and therefore was not affected by recall bias; data on birthweight
were not available for only 0.5% of women. Incomplete follow-up
was minimized because, as well as having frequent contacts, the
cohort has been flagged through the NHSCR since 1971, losses
before then being essentially due to deaths and emigrations at
young ages. Of the 37 breast cancer cases identified, 14 were self-
reported as well as identified through flagging, 16 were only self-
reported because they occurred after 1992 (the last year for which
NHSCR data are available) and six, although identified only
through flagging, were women with whom there was no direct
contact. Only one woman reported a diagnosis of breast cancer
before 1992 but did not appear in the NHSCR system. The number
of identified breast cancer cases appears therefore to be complete
and indeed was similar to that expected on the basis of national
incidence rates (37 observed, 36.8 expected). A final point in
support of our results is that we were able to examine whether the
effect of birthweight on breast cancer was confounded or modified
by markers of childhood growth and adult-life risk factors for
breast cancer.
The study also presented some limitations. First, as in some
previous studies (Michels et al, 1996; Sanderson et al, 1996), there
was no information on gestational age and it is conceivable that
weight relative to gestational age may be more important than just
birthweight. However, this would have led, if anything, to an
underestimation of the effect of the growth process in utero on
breast cancer risk. Second, the cohort is still relatively young and
the number of breast cancer cases relatively small. Future re-
analysis of follow-up data from this cohort, when more cases will
have been accrued, will provide more precise estimates and allow
separate analyses at postmenopausal ages. Last, information on
potential confounding or modifying factors was not available for a
substantial minority of the cohort members. However, the results
obtained from the subsets of women with information on the
different confounders were in broad agreement with each other,
while those for women with data on height at age 7 were based on
86% both of the cohort (1909 out of 2221) and of the cases (32 out
of 37). Hence it seems unlikely that the exclusions would explain
the height results.
Although the effect of birthweight on breast cancer risk is
compatible with the hypothesis that growth processes in utero are
important in the aetiology of this tumour, our data suggest that
exposures in early childhood are also relevant. Our study identi-
fied a strong statistical interaction between the effects of birth-
weight and height at age 7 (and, to a lesser extent, height at age 
6 and 11, and age at menarche). The lack of interaction at age 
2 argues against the interpretation that information on birthweight
plus height at age 7 simply gives a better marker of fetal growth
than information on birthweight alone. There was no significant
interaction with height at 15 or adult height, suggesting that rate of
childhood growth, rather than height per se, is the important factor.
The results are therefore consistent with the hypothesis that nutri-968 BL De Stavola et al
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tion during childhood may modulate the effect of birthweight on
breast cancer risk (De Waard and Trichopoulos, 1988) since both
height and age at menarche seem to be influenced by nutritional
status early in life (Frisch, 1987; Stoll et al, 1994). A recent
prospective study showing a strong association between leg length
measured before age 8 years and breast cancer mortality lends
support to this idea (Gunnell et al, 1998).
Birthweight has been found to be positively associated with
high levels of pregnancy oestrogens in some studies (Petridou et
al, 1990; Trichopoulos, 1990) and breast cancer with being a dizy-
gotic twin (Braun et al, 1995; Swerdlow et al, 1997), which
evidence suggests may be of hormonal origins (Nylander, 1981;
Martin et al, 1984; Kappel et al, 1985). Moreover, the increase in
breast cancer risk in dizygotic twins has been restricted to young
ages, like the relationship with birthweight which we, and others
(Michels et al, 1996; Sanderson et al, 1996), have found. High
birthweight may also reflect the role of other hormones such as
insulin-like growth factors (IGFs) which are important regulators
of somatic growth during fetal life and childhood (Holly, 1998).
High levels of IGFs may also result in an increased number of
stem cells and/or increased mitosis in the mammary gland. A
recent prospective study showed a strong association between
adult circulating levels of IGF-I and later development of pre-
menopausal (but not postmenopausal) breast cancer (Hankinson
et al, 1998). So endocrine factors may underlie the processes that
determine both size at birth and height at age 7, as well as their
interaction.
In summary, our findings are consistent with the hypothesis that
the effect of birthweight on breast cancer risk is subsequently
modulated by childhood growth. They also emphasize the need to
examine breast cancer aetiology by taking into account risk factors
that operate pre-natally or at other stages of life (Kuh and Ben-
Shlomo, 1997).
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